GRID Consulting, established in 2007 in Switzerland, was initially founded by Prof. Dr. Robert Steffen, to address the global threat of avian influenza. During the same decade, the organization expanded significantly with the addition of new partners: Ralf Clemens, Sue Ann Costa Clemens, and Hans Bock. This expansion facilitated the opening of additional branches in Europe, Latin America, and Singapore.
The expertise brought by these advisors has been instrumental in broadening GRID Consulting’s reach and capabilities. Ralf Clemens is known for his work in vaccinology, translational medicine, and global health, while Sue Ann Costa Clemens has been recognized for her contributions to public health, particularly in pediatrics and infectious diseases; Hans Bock is a global leader in strategic and organizational set up for high efficiency execution of late stage development and launches. Through the involvement of the 3 partners also the geographical reach was substantially expanded.
This growth underscores GRID Consulting’s commitment to its mission of contributing to the prevention of infectious diseases on a global scale. GRID Consulting aims to enhance global health security by developing innovative solutions and forming strategic partnerships. The organization focuses on creating comprehensive strategies to combat infectious diseases, ensuring they remain at the forefront of public health initiatives worldwide.
The Mission
To contribute to prevention against infectious diseases, globally
The founder
Emeritus Prof. Dr. Robert Steffen, MD
Prof. Dr. Robert Steffen, Professor Emeritus at the University of Zurich was the Head of the Division of Communicable Diseases in the Epidemiology, Biostatistics and Prevention Institute and Director of a World Health Organization (WHO) Collaborating Centre for Traveller’s Health. He also is Adjunct Professor at the University of Texas School of Public Health in Houston.
The Partners
Prof. Dr. Sue Ann Costa Clemens, MD, M.Sc, PhD, CORB, COMM, CBE
Prof. Dr. Sue Ann Costa Clemens is currently Professor of Pediatrics Infectious Diseases, Head of the Institute for Global Health University of Siena and Director Vaccine Group Oxford-Brazil, Full Professor in Global Health at Oxford University, Department of Paediatrics.
Prof. Dr. Ralf Clemens, MD, PhD
Prof. Dr. Ralf Clemens is currently serving as Advisor to the Bill & Melinda Gates Foundation and chair/ member of management/scientific boards of various global Biotechs. Before he was Senior Vice President/ Head Global Vaccines Development at GSK, Novartis and Takeda Vaccines. At GSK Vaccines he was additionally in charge of developing country business strategies and technology transfers to developing country vaccine manufacturers.
Dr. Hans Bock, MD, PhD
Hans Bock is a seasoned professional with extensive experience in the biotech and pharmaceutical industries. He is currently the Chairman of the Advisory Board at Celero, a company dedicated to providing optimal returns to innovative biotechs. Hans has held this position since April 2024.
Worldwide reach
